- HK$31.19bn
- HK$31.02bn
- CNY9.11bn
- 97
- 44
- 100
- 94
Annual income statement for 3SBio, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5,588 | 6,382 | 6,866 | 7,816 | 9,108 |
Cost of Revenue | |||||
Gross Profit | 4,525 | 5,276 | 5,672 | 6,642 | 7,828 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4,497 | 4,410 | 4,449 | 5,595 | 6,548 |
Operating Profit | 1,091 | 1,972 | 2,417 | 2,221 | 2,560 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 979 | 1,869 | 2,280 | 1,978 | 2,718 |
Provision for Income Taxes | |||||
Net Income After Taxes | 771 | 1,628 | 1,909 | 1,586 | 2,218 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 836 | 1,651 | 1,916 | 1,549 | 2,090 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 836 | 1,651 | 1,969 | 1,525 | 2,090 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.353 | 0.605 | 0.821 | 0.609 | 0.866 |
Dividends per Share |